Literature DB >> 16557991

Interferon system in cells from human tumors and from persons predisposed to cancer.

M Worthington1, S A Aaronson.   

Abstract

In the present study, the interferon system was evaluated in fibroblasts from persons predisposed to leukemia or other cancers, in fibroblasts from persons with neoplastic disease, and in human tumor cells. Of 31 normal fibroblast strains from patients with tumors or diseases associated with a high incidence of malignancy, only one cell strain had a poor response to either of the two interferon inducers used, polyinosinic-polycytidylic acid and Chikungunya virus. On the other hand, cell cultures of five human tumors were much less sensitive to the antiviral effect of these interferon inducers and of human interferon and produced less interferon in response to Chikungunya virus than any of the nontumor tissues studied.

Entities:  

Year:  1971        PMID: 16557991      PMCID: PMC416169          DOI: 10.1128/iai.3.3.424-428.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Productive infection and morphologic alteration of human cells by a modified sarcoma virus.

Authors:  P J Fischinger; T E O'Connor
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics.

Authors:  H M SHEIN; J F ENDERS
Journal:  Proc Natl Acad Sci U S A       Date:  1962-07-15       Impact factor: 11.205

3.  [An inhibiting factor of intracellular multiplication of viruses called interferon, originating from cancer cells. The phenomenon of viral autoinhibition].

Authors:  C CHANY
Journal:  C R Hebd Seances Acad Sci       Date:  1960-06-08

4.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

5.  Human sarcoma cells in culture. Identification by colony-forming ability on monolayers of normal cells.

Authors:  S A Aaronson; G J Todaro; A E Freeman
Journal:  Exp Cell Res       Date:  1970-07       Impact factor: 3.905

6.  Antitumor effects of interferon preparations in mice.

Authors:  I Gresser; C Bourali
Journal:  J Natl Cancer Inst       Date:  1970-08       Impact factor: 13.506

7.  Influence of PPLO on production of interferon in virus-infected cells.

Authors:  F I Yershov; V M Zhdanov
Journal:  Virology       Date:  1965-11       Impact factor: 3.616

8.  [Factors antagonizing the antiviral action of interferon extracts of different human sarcomas].

Authors:  C Chany; J Lemaître; A Grégoire
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1969-12-22

9.  Human liposarcomas: tissue cultures containing foci of transformed cells with viral particles.

Authors:  D L Morton; W T Hall; R A Malmgren
Journal:  Science       Date:  1969-08-22       Impact factor: 47.728

10.  Virus-induced sarcoma of mice: inhibition by a synthetic polyribonucleotide complex.

Authors:  P S Sarma; G Shiu; R H Neubauer; S Baron; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

View more
  4 in total

1.  T-antigen expression in human skin fibroblasts is not regulated by an endogenous interferon response to SV40 infection.

Authors:  A S Lubiniecki; W A Blattner; V Cruttenden; M Gunnell; G C Tarr; J F Fraumeni
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  Production of interferon by human tumor cell lines.

Authors:  P Jameson; S E Grossberg
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Interferon production by human cells in vitro.

Authors:  C A Spin; R S Chang; L Mishra; H D Golden
Journal:  Appl Microbiol       Date:  1972-11

Review 4.  Oncolytic polio virotherapy of cancer.

Authors:  Michael C Brown; Elena Y Dobrikova; Mikhail I Dobrikov; Ross W Walton; Sarah L Gemberling; Smita K Nair; Annick Desjardins; John H Sampson; Henry S Friedman; Allan H Friedman; Douglas S Tyler; Darell D Bigner; Matthias Gromeier
Journal:  Cancer       Date:  2014-06-17       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.